Heterogeneous benefit of early sacubitril/valsartan initiation after PCI in elderly patients with left ventricular dysfunction: myocardial recovery and mid-term cardiovascular outcomes - Top-Institutions - MDSpire

Heterogeneous benefit of early sacubitril/valsartan initiation after PCI in elderly patients with left ventricular dysfunction: myocardial recovery and mid-term cardiovascular outcomes

  • By

  • Jian Li

  • Chunxia Tang

  • May 29, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Wuxi People's Hospital
    Wuxi People's Hospital

    Wuxi, Jiangsu

    Key Differentiators

    • Cardiology

  • #2

    Deutsches Herzzentrum München
    Deutsches Herzzentrum München

    Munich, Bavaria

    Key Differentiators

    • Cardiology

  • #3

    Second Hospital of Hebei Medical University
    Second Hospital of Hebei Medical University

    Shijiazhuang, Hebei

    Key Differentiators

    • Cardiology

Original Source(s)

Heterogeneous benefit of early sacubitril/valsartan initiation after PCI in elderly patients with left ventricular dysfunction: myocardial recovery and mid-term cardiovascular outcomes

  • by Jian Li, Chunxia Tang

  • May 29, 2026

Related Content

Biomolecular mechanisms of cardiac amyloidosis and its cardiovascular pathological basis

FDA Approves Baxdrostat for Resistant Hypertension

Phase 3 findings support the oral therapy in adults with persistent blood pressure elevation despite multidrug treatment.

Predictive value of the uric acid-to-albumin ratio for contrast-induced nephropathy after percutaneous coronary intervention and construction of a clinical prediction model in patients with coronary artery disease